Evidence map›Paper›PMID 42461483›Full record

ArticleAIDS and behavior2026

Characterizing the Geography of Drug Use Networks and Behaviors Among People Who Inject Drugs in the Baltimore Metropolitan Region.

Amy Wesolowski, Catherine Schluth, Kyra H Grant, Danielle German, Carl Latkin, Gregory M Lucas, Gregory D Kirk, Shruti H Mehta, Becky L Genberg

Abstract read
PubMed Publisher
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Amy WesolowskiDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA. awesolowski@jhu.edu.ORCID http://orcid.org/0000-0001-6320-3575
Catherine SchluthDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Kyra H GrantDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Danielle GermanDepartment of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Carl LatkinDepartment of Health Behavior and Society, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Gregory M LucasDepartment of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
Gregory D KirkDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Shruti H MehtaDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Becky L GenbergDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

Funding

Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Anna Palmer Durbin · 2012 to 2026
$67.0M
Center for AIDS Research, Johns Hopkins University 1P30AI094189National Science Foundation NSF-23-546NIAID NIH HHS P30 AI094189NIDA NIH HHS R01-DA-053136NIDA NIH HHS U01-DA-036297
6 · The paper itself

Abstract

The geography of injection drug use in the United States continues to evolve and expand outside of urban areas, yet there is little understanding of the extent to which urban and non-urban networks of people who inject drugs (PWID) interact, which has implications for HIV and hepatitis C transmission (HCV). Here, we characterize individuals with mixed geography PWID networks in the Baltimore, Maryland region, as well as prospective associations with injection-related risk behaviors. Nested within the AIDS Linked to the IntraVenous Experience (ALIVE) study, an ongoing community-based cohort of former and current PWID in Baltimore, Maryland, we conducted an ego-centric drug use network survey among n = 237 PWID who reported any injection drug use in the last 12 months from across the metropolitan region in 2018-2019 and examined prospective associations between network geography and injection drug use, sharing, and non-fatal overdose at 6-month follow-up visits. Of the 237 individuals surveyed, 59% (n = 141) had exclusively city-based networks and 41% (n = 87) had mixed-geography networks (defined as ego or at least one network tie with residential location outside of the city). Compared to PWID with uniformly city-based networks, those with mixed-geography networks were more likely to report sharing needles and injection equipment on follow-up, after adjusting for individual characteristics. Network-based interventions focused on PWID who cross geographic borders may be important to stay ongoing HCV transmission and prevent HIV resurgence.

Indexed as

GeographyNetworksPWIDUrban

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.